Important pharmacy news and late-breaking industry information updated daily.
Researchers announced on Wednesday the discovery of a new strain of HIV, the first new strain of the virus identified since 2000. According to Abbott Laboratories, which conducted the research along with the University of Missouri, Kansas City, the strain is part of the Group M version of HIV-1.
Mint and mango are the most popular flavors of JUUL e-cigarettes among U.S. teenagers, new research shows. The study used data from the Monitoring the Future (MTF) study, a nationally representative samples of U.S. 8th-grade, 10th-grade, and 12th-grade students earlier this year.
In the ongoing investigation into the detection of N-nitrosodimethylamine (NDMA) in ranitidine (Zantac) medications, FDA said it has "found levels of NDMA in ranitidine that are similar to the levels you would expect to be exposed to if you ate common foods like grilled or smoked meats."
A new study examines the case of a woman with a genetic mutation that often causes memory and thinking problems for people starting in their 40s, but she experienced no cognitive decline until she reached her 70s.
In the ongoing investigation into the detection of N-Nitrosodimethylamine (NDMA) in ranitidine (Zantac) medications, an FDA official said Friday the agency "found levels of NDMA in ranitidine that are similar to the levels you would expect to be exposed to if you ate common foods like grilled or smoked meats." According to Janet Woodcock, MD, direc
Telecontraception is proving to be another option for women to access hormonal contraceptives. Several telecontraception vendors exist that connect patients—through a website or smartphone app—to prescription hormonal contraceptives. Virtual visits include a questionnaire that patients must fill out. Women can receive the prescription hormonal contraceptives at their local pharmacy after completing this questionnaire online.
Data unveiled Thursday revealed that a new cystic fibrosis therapy dramatically improved patients' lung function and showed clear signs of targeting the genetic root of the disease, instead of just alleviating symptoms.
In August 2019, the U.S. Preventive Services Task Force (USPSTF) released an updated statement on recommendations for risk assessment, genetic counseling, and genetic testing for BRCA mutations in women who are cancer free and do not know their mutation status. The organization recommends risk assessment be performed in women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have ancestry associated with harmful BRCA1/2 mutations. Those with a positive result on the risk assessment tool should be referred for genetic counseling and, if indicated after counseling, genetic testing. USPSTF recommends against BRCA1/2 assessments for women who have no personal or family history of the potentially harmful gene mutation, as the benefits are small to none.
In a medical breakthrough, two new drugs are saving lives from the Ebola virus and helping uncover tools against other deadly infectious diseases. They were proven effective in a gold-standard clinical trial conducted by an international coalition of doctors and researchers in the middle of armed violence.
FDA released on Tuesday a report from the inter-agency Drug Shortages Task Force.